somatic mutations

Related by string. somatic mutation * Somatic . Somatics : somatic cell reprogramming . somatic cell nuclear . Somatic Systems . somatic symptoms . somatic cells . somatic cell count . somatic cell . Clinical Somatics / Mutations . Mutation : gene mutation . gene mutations . G#D mutation . genetic mutations identical . inherited mutations . activating mutations . spontaneous mutation * *

Related by context. All words. (Click for frequent words.) 76 genomic alterations 74 chromosomal rearrangement 74 chromosomal aberrations 73 miRNA expression 73 splice junctions 73 missense mutations 72 microdeletions 72 MSH2 71 mtDNA mutations 71 gene rearrangements 71 de novo mutations 71 aneuploidies 71 noncoding RNAs 71 microRNA expression 71 somatic mutation 71 gene amplification 71 paralogs 70 virulence genes 70 proto oncogene 70 BRCA1 BRCA2 70 non coding RNA 70 causative mutations 70 molecular abnormalities 70 hamartomas 70 histone modifications 70 PARP inhibition 70 activating mutation 70 PTEN gene 70 nucleotide substitutions 70 indel 70 pathogenic mutations 70 monogenic 70 immunohistochemical analysis 70 #S rRNA 69 splice variants 69 Clusterin 69 germline mutations 69 epigenetic mechanisms 69 hypermethylated 69 differential gene expression 69 PALB2 69 PIK3CA 69 mitochondrial gene 69 microRNA molecules 69 PTPN# 69 segmental duplications 69 molecular biomarkers 69 #S rRNA gene 69 noncoding 69 ALK mutations 69 DNA methylation patterns 69 Prox1 69 KRAS oncogene 69 sequence homology 69 miRNA genes 69 genetic aberrations 69 K ras mutations 69 FGFR2 69 genetic loci 68 Alu elements 68 CYP#D# gene 68 WT1 68 differentially expressed genes 68 epigenetic modification 68 chromosome aberrations 68 epigenetic alterations 68 HbF 68 CHEK2 68 genomic rearrangements 68 uPAR 68 Microarray analysis 68 genomewide 68 nucleotide sequence 68 microRNAs miRNAs 68 MAPK pathway 68 mutational analysis 68 ncRNA 68 TP# mutation 68 ependymomas 68 beta1 integrin 68 phylogenetic analyzes 68 OGG1 68 GPC5 68 conserved sequences 68 differentially expressed proteins 68 RRM1 68 promoter methylation 68 tumor suppressor protein 68 Activating mutations 68 VNTR 68 epithelial tumors 68 ZNF# 68 RNA transcripts 68 Immunohistochemical analysis 67 ncRNAs 67 genomic deletions 67 #q#.# [002] 67 CHD5 67 mutated K ras 67 putative biomarkers 67 HER2 gene 67 Cytogenetic 67 hypermethylation 67 inactivating mutations 67 TMPRSS2 ERG fusion 67 indels 67 alternatively spliced 67 tumor biopsies 67 trophoblast cells 67 epigenetic modifications 67 genomic loci 67 RNA polymerases 67 TP# gene 67 LRP5 67 genetic polymorphisms 67 microarray gene expression 67 RNA sequences 67 #q#.# [001] 67 Western blotting 67 mRNA transcripts 67 ribosomal DNA 67 hyperplastic 67 susceptibility loci 67 miRNAs 67 orthologs 67 coding genes 67 chromosomal deletions 67 diagnostic biomarker 67 renal cell carcinomas 67 LRRK2 gene 67 HLA alleles 67 BRAF V#E 67 previously uncharacterized 67 Brugada syndrome 67 p# mutations 67 cDNAs 67 JAK2 enzyme 67 microdeletion 67 methylated DNA 67 tumorigenicity 67 DNA demethylation 67 C1q 67 germline mutation 67 methylation markers 66 primate genomes 66 transgene expression 66 prognostic markers 66 promoter hypermethylation 66 HOTAIR 66 gene loci 66 herpesviruses 66 mosaicism 66 breast carcinomas 66 RNA ribonucleic acid 66 protein coding RNAs 66 VHL gene 66 TCF#L# gene 66 chromosomal rearrangements 66 BRAF gene 66 IDH1 mutation 66 quantitative RT PCR 66 seminomas 66 gene fusions 66 MLH1 66 TTR gene 66 microarray experiments 66 ABL1 66 EGF receptors 66 activating mutations 66 p tau 66 nucleolar 66 allelic variants 66 protein isoforms 66 Cathepsin B 66 Immunohistochemical staining 66 mutations 66 sCJD 66 heterozygotes 66 chromosomal translocations 66 comparative genomic hybridization 66 clefting 66 NSCLC tumors 66 EGFR gene 66 aCGH 66 hypomethylation 66 IgA deficiency 66 immunohistochemical 66 coding exons 66 non coding RNAs 66 Genetic variants 66 cDNA libraries 66 prostate carcinoma 66 chromosome #q# [001] 66 miRNA molecules 66 causal variants 66 normal karyotype 66 myelofibrosis polycythemia vera 66 3'UTR 66 H#K#me# 66 gene expression microarrays 66 pituitary adenomas 66 biochemical abnormalities 66 tyrosine phosphorylation 66 proteomic analysis 66 SNP rs# [001] 66 bacterial genomes 66 NFKBIA 66 c myb 66 genes differentially expressed 66 genetic polymorphism 66 pilocytic astrocytomas 66 urothelial carcinoma 66 mitochondrial DNA mtDNA 66 precursor lesions 66 chromosomal anomalies 66 chromosomal regions 66 transcriptional profiling 66 CDH1 66 androgen receptor AR 66 mesotheliomas 66 mRNA molecules 66 FGFs 66 microcephalin 66 methylation patterns 66 isotype 66 gene expression patterns 66 bronchial epithelial cells 66 chromatin immunoprecipitation ChIP 66 short hairpin RNAs 66 immunostaining 65 Cx# [001] 65 GIST tumors 65 malignant phenotype 65 Sanger sequencing 65 modifier genes 65 DNA rearrangements 65 biochemical assays 65 genetic determinants 65 antisense oligonucleotides 65 biomarker identification 65 micro RNAs 65 chromosome #q#.# [001] 65 insertions deletions 65 chromosome rearrangements 65 protein tyrosine phosphatase 65 c Myb 65 Stat5 65 mRNA expression 65 extramedullary 65 histone acetylation 65 histone modification 65 microsatellite instability 65 CREBBP 65 chromosome abnormalities 65 SCN5A 65 Protein Kinase C 65 constitutively expressed 65 K#N 65 metaplasia 65 microglial 65 genomic instability 65 COL#A# 65 WDR# 65 MLL2 65 micro RNA 65 ALK gene 65 genetic rearrangements 65 quantitative trait loci 65 malignant nodules 65 piRNAs 65 p# MAPK 65 DEAR1 65 TMPRSS2 ERG 65 #q# deletion 65 beta globin gene 65 chromosome #p#.# 65 transcriptomes 65 sporadic ALS 65 microRNA biomarkers 65 chromosome translocations 65 intergenic 65 Dpp 65 MMP9 65 hepatocellular carcinomas 65 mucinous 65 ERK signaling 65 posttranslational modifications 65 Phenotypic 65 DSBs 65 spontaneous mutations 65 Immunohistochemistry 65 HER2 expression 65 PCA3 gene 65 transcriptome profiling 65 HER2 overexpression 65 genomic variants 65 haematopoietic 65 positional cloning 65 viral genomes 65 KRAS mutations 65 DNMT1 65 KRAS mutation 65 ALK inhibitors 65 NF kB pathway 65 cisplatin resistant 65 SHANK3 65 Fas ligand 65 etiologic 65 CDKN2A 65 epithelial tissues 65 FUS1 65 N Myc 65 PrPSc 65 distinct subtypes 65 BCL#A 65 N. gonorrhoeae 65 chromosome #q# [002] 65 susceptibility gene 65 Histologically 65 SOD1 gene 65 array CGH 65 #S rDNA 65 neuroblastomas 65 rRNA 65 EBNA1 65 causative genes 65 mutant alleles 65 SPINK1 65 gene rearrangement 65 ultrastructural 65 causative mutation 65 Single Nucleotide Polymorphisms SNPs 65 benign neoplasms 65 BRAF mutations 65 NKX#.# 65 epigenetic changes 65 inherited mutations 64 ADPKD 64 miRNA profiling 64 KLF4 64 qRT PCR 64 splice variant 64 cAMP signaling 64 TET2 64 variant allele 64 rs# [004] 64 dinucleotide 64 miRs 64 Epstein Barr virus EBV 64 EGFR mutations 64 transcriptomic 64 cis regulatory 64 FLT3 64 apoE4 64 susceptibility genes 64 carcinoids 64 GSTP1 64 genome rearrangements 64 transcriptional regulation 64 karyotype 64 CIN2 + 64 Histologic 64 S. maltophilia 64 BCR ABL mutations 64 paraffin embedded 64 immunoblotting 64 FGFR3 64 KCNH2 64 prostate cancer CaP 64 Estrogen Receptor 64 medulloblastomas 64 mutant allele 64 immunofluorescent 64 #p# [003] 64 genotoxic stress 64 breast cancer subtypes 64 genetic variants associated 64 serine threonine kinase 64 allelic 64 KIT mutations 64 gene polymorphisms 64 metabolomic profiles 64 phenotypic variation 64 serine protease 64 TGFBR1 * 6A 64 molecular subtypes 64 single nucleotide polymorphism 64 ERBB2 64 Wnts 64 primary cilia 64 gastrointestinal stromal tumors GISTs 64 transgenic mouse models 64 epigenetic markers 64 thyroid carcinoma 64 squamous cell lung cancer 64 EphA2 64 molecular determinants 64 ChIP Seq 64 chromosomal mutations 64 C#Y 64 Methylation 64 β1 64 Haplotype 64 missense mutation 64 APOE e4 64 Smad3 64 adenocarcinomas 64 bisulfite sequencing 64 E#F# 64 childhood leukemias 64 leiomyomas 64 HLA DQ2 64 quasispecies 64 MiRNAs 64 siRNA knockdown 64 TOP2A 64 hepatic stellate cells 64 NR#A# gene 64 histologic subtype 64 mitochondrial proteins 64 miR #a [002] 64 histocompatibility 64 untranslated regions 64 gene locus 64 mutational status 64 thiopurine 64 Li Fraumeni 64 #p# [001] 64 SMAD4 64 PBMCs 64 oncogenesis 64 KRAS BRAF 64 genetic locus 64 Papillary 64 karyotypes 64 costimulatory 64 V#F mutation 64 genomewide association studies 64 nonsense mutations 64 cysteines 64 CHD7 64 FGFR2 gene 64 cardiac troponin T 64 embryonal 64 clusterin 64 clade B 64 malignant prostate 64 electrophysiologic 64 subcellular compartments 64 astrocytic 64 renal cysts 64 Hurthle cell 64 chromosomal instability 64 experimentally validated 64 Upregulation 64 myopathies 64 microRNAs 64 BDNF gene 64 hepatoma 64 isotypes 64 pDCs 64 gene deletions 64 carcinoembryonic antigen 64 C#T [002] 64 papillary renal cell carcinoma 64 maternally inherited 64 intronic 64 intergenic regions 64 PI3K AKT 64 gastric carcinoma 64 homodimers 64 ABCB1 64 gastric adenocarcinoma 64 FDG PET scans 64 Wnt signaling pathway 64 hematopoietic cells 64 p# biomarker 64 aneuploid cells 64 nucleotide sequences 64 ERK1 2 64 aneuploidy 64 comparative genomic hybridization CGH 64 meningiomas 64 methylation 64 SNP rs# [002] 64 pre malignant lesions 64 underlying molecular mechanisms 64 Situ Hybridization 64 FGF signaling 64 anterior pituitary 64 situ hybridisation 64 outer membrane proteins 64 progranulin gene 64 nucleated cells 64 phenotypic expression 64 quantitative PCR 64 immunopathology 64 thyroglobulin 64 transcriptional profiles 64 vimentin 64 Cre recombinase 64 annexin V 64 Genetic mutations 64 Epstein Barr Virus EBV 64 granzyme B 64 liver metastasis 64 serum antibodies 64 RT qPCR 63 neuroblastoma tumors 63 #F FDG PET 63 colorectal carcinoma 63 metazoan 63 CpG island 63 ccRCC 63 ChIP seq 63 prognostic biomarker 63 MTHFR 63 IDH1 63 AMACR 63 biologic pathway 63 allele frequencies 63 mammalian genomes 63 nucleic acid sequence 63 P cadherin 63 morphologic 63 #S rRNA genes 63 chromosome #p# [001] 63 multiplex assay 63 previously undescribed 63 TOP2A gene 63 RUNX3 63 ribonucleic acids 63 androgen receptor gene 63 immunoregulation 63 pathogenic mechanisms 63 SLITRK1 63 heterozygosity 63 amplicons 63 BARD1 63 histological subtype 63 LKB1 63 cardiac troponin 63 TSLP 63 MMP# 63 Tr DNA 63 nodal metastasis 63 NPM1 mutations 63 PCa 63 gene expression profiles 63 polymorphisms 63 Oncogenic 63 neoplastic 63 protein phosphorylation 63 C. pneumoniae 63 protein conformation 63 p# activation 63 exome 63 substrate specificity 63 M. pneumoniae 63 K ras gene 63 HepG2 cells 63 circadian genes 63 B7 H3 63 PDGFR 63 mutant genes 63 #p#.# [001] 63 motor neuron degeneration 63 breast carcinoma 63 druggable targets 63 drug metabolizing enzymes 63 CNVs 63 transcriptional repressor 63 FGFR1 63 Genotypes 63 histologic subtypes 63 SCN1A 63 shRNAs 63 uncharacterized genes 63 immunohistochemical staining 63 flavopiridol 63 CFTR gene 63 EBV infection 63 Notch signaling pathway 63 exomes 63 osteosarcomas 63 DNA methyltransferases 63 metastatic lymph nodes 63 telomere DNA 63 multiplex ligation dependent 63 Jhdm2a 63 transmembrane proteins 63 epigenetically 63 RASSF1A 63 peptide antigens 63 morphogen 63 RNA splicing 63 hepatic stellate cell 63 aggregated Abeta 63 paraganglioma 63 microRNA genes 63 stratifying patients 63 murine models 63 tumor suppressor gene 63 STK# gene 63 breast cancer metastasis 63 phosphorylated proteins 63 apoE 63 imprinted genes 63 Htt 63 human leukocyte antigens 63 adenylate cyclase 63 lincRNAs 63 GPx 63 orthologous 63 flow cytometric analysis 63 prion infection 63 protein encoded 63 H#Y 63 CRISPR 63 lincRNA 63 chromatin structure 63 mutated genes 63 engineered RAP peptides 63 transgenic rats 63 Transcriptome 63 glial tumors 63 TSC1 63 deleterious mutations 63 telomeric 63 coding sequences 63 hematopoietic cancers 63 DLC1 63 TAp# 63 lymphoid tissues 63 ribonucleic acid RNA 63 gastric carcinomas 63 GBM tumors 63 antibody mediated 63 PHLPP 63 aT cell 63 p# alpha [002] 63 transgenic mouse model 63 mammary stem cells 63 angiographically 63 genomic variation 63 silico prediction 63 Her2 gene 63 FMR1 gene 63 IL#B 63 BRAF protein 63 Six3 63 tumor subtypes 63 tumor hypoxia 63 coexpression 63 colorectal tumor 63 COX2 63 GNAQ 63 gene duplications 63 atypical hyperplasia 63 genes CYP#C# 63 5 hydroxymethylcytosine 63 plasma kallikrein 63 Mutational 63 CCR1 63 metabolic enzymes 63 6S RNA 63 prostanoid 63 antisense inhibitors 63 IKZF1 63 alternative splicing 63 ERK2 63 c KIT 63 HMGA2 63 PML RARA 63 proton MR spectroscopy 63 Arabidopsis genome 63 MAP kinase pathway 63 MYH9 63 protein p# 63 mesenchymal cell 63 familial clustering 63 KCNQ1 63 E. faecalis 63 sarcosine 63 VKORC1 63 PKM2 63 Trichophyton rubrum 63 p#INK#a 63 penetrance 63 cytosine methylation 63 endophenotypes 63 γ secretase 63 supratentorial 63 orthologous genes 63 immunochemical 63 FGFR4 63 eTag assays 63 MC4R gene 63 CEACAM1 63 LRAT 63 epistasis 63 epigenetic regulation 63 ERK pathway 63 c myc 63 receptor tyrosine kinase 63 nucleases 63 biochemical marker 63 MECP2 gene 63 MGUS 63 rifamycins 63 CD8 + 63 #q# [002] 63 connexin 63 SMN1 63 Fibroblast 63 immunodominant 63 CNTNAP2 63 ligand receptor 63 chemosensitivity 63 polyadenylation 63 microsatellite markers 63 Nedd4 63 Epidermal Growth Factor Receptor 63 CSHL scientists 63 histopathologic 62 cytochrome b 62 osteoblastic 62 histopathologic examination 62 autoantibodies 62 LRRK2 mutation 62 HGPIN 62 metalloprotease 62 transmembrane protein 62 SLC#A# [002] 62 mesothelin 62 monocytes macrophages 62 viral genome 62 aberrant methylation 62 cellular pathways 62 melanocyte 62 prognostic significance 62 KIAA# 62 CGG repeats 62 TPMT 62 vacuolar 62 MDR1 62 scintigraphic 62 histone deacetylase inhibitors 62 Xenopus embryos 62 colorectal carcinomas 62 MALAT1 62 HNPCC 62 miR #a [001] 62 LIS1 62 S#A# [002] 62 RNA viruses 62 mycobacterial 62 replicase 62 #p#.# [002] 62 breast cancer genes BRCA1 62 fluorescently labeled 62 transthyretin 62 genes BRCA1 62 endostatin 62 genomic rearrangement 62 nonmelanoma skin cancers 62 proteolytic cleavage 62 serous ovarian cancer 62 EphB4 62 Leydig cells 62 proteomes 62 NF1 gene 62 TRAIL induced apoptosis 62 amino acid residues 62 amyloid deposits 62 biologic pathways 62 situ hybridization 62 intracellular bacteria 62 C. albicans 62 HER2 neu 62 genes encoding 62 prostate adenocarcinoma 62 genomic profiling 62 ANGPTL4 62 MAPCs 62 Phosphorylation 62 JAK mutations 62 Anticalins ® 62 adenomatous polyps 62 replicon 62 gene APOE4 62 tumor suppressor genes 62 Polymorphisms 62 Confocal microscopy 62 Cyclin D1 62 PPARγ 62 gene mutations 62 mutant proteins 62 neoplastic cells 62 proteomic analyzes 62 Fibroblast Growth Factor Receptor 62 globin genes 62 biomarkers 62 PKD1 62 endogenous ligands 62 lung carcinomas 62 tissue microarrays 62 homologous genes 62 adenoviral 62 deacetylation 62 TLE3 62 NGAL 62 eukaryotic genomes 62 epithelia 62 spontaneous mutation 62 transcriptome sequencing 62 CagA 62 enterotypes 62 lymphoblastoid cell lines 62 genomic biomarker 62 multiprotein complex 62 GBA mutations 62 Treg cell 62 familial ALS 62 evolutionarily conserved 62 ubiquitin ligases 62 MeCP2 gene 62 osteochondromas 62 Kv#.# 62 pancreatic endocrine 62 metastatic neuroendocrine tumors 62 RQ PCR 62 neuroinflammation 62 apoptotic pathway 62 parkin gene 62 Polymorphism 62 thyroid carcinomas 62 steroidogenic 62 ligand binding 62 reverse vaccinology 62 C. neoformans 62 HLA genes 62 CD4 + T lymphocytes 62 histone H4 62 subcellular localization 62 glycolipids 62 PI3K Akt 62 granulosa cell 62 Notch signaling 62 induced sputum 62 CD# expression [001] 62 RT PCR assay 62 secretory pathway 62 sphingolipid 62 MYBPC3 62 luciferase reporter 62 rs# [002] 62 chemokine receptors 62 Nup# 62 atherosclerotic lesions 62 IDH mutations 62 HLA DRB1 62 hemagglutinin gene 62 5 hmC 62 Peutz Jeghers syndrome 62 NF kB signaling 62 GSTT1 62 MicroRNAs 62 tumor specific antigen 62 GLUT1 62 Arabidopsis genes 62 isoforms 62 autism susceptibility genes 62 genetic alterations 62 chemoresistant 62 Genetic variation 62 MTHFR gene 62 Hashimoto thyroiditis 62 fruitfly Drosophila 62 hyperactivation 62 histone deacetylases 62 N glycan 62 abnormal proteins 62 hematopoietic progenitor cells 62 meiotic recombination 62 myeloproliferative diseases 62 APOL1 62 HCT# 62 autosomal 62 gliosis 62 caveolin 1 62 renal tumors 62 linkage disequilibrium 62 anti angiogenic drugs 62 SMN2 62 Genotypic 62 unmethylated 62 CDK4 62 phosphoprotein 62 etiologic agent 62 SAXS 62 genetic biomarkers 62 underlying pathophysiology 62 lymphangiogenesis 62 MEF2A 62 MIF protein 62 phylogenetic analysis 62 cell nuclei 62 telomere lengths 62 ChIP chip 62 colorectal adenocarcinoma 62 functional polymorphism 62 BRAF V#E mutation 62 chromosomal abnormalities 62 lymphoid cells 62 Leukemias 62 cDNA microarray 62 p# mutation 62 chemokine receptor 62 IGFBP2 62 GISTs 62 ORMDL3 62 HDACs 62 protein misfolding 62 Drosha 62 mTOR inhibitors 62 transcriptomics 62 fungal genomes 62 pleomorphic 62 MC1R gene 62 malignant transformation 62 potent inhibition 62 Foxp3 62 bacterial virulence 62 EZH2 62 Lymph node 62 gene expression 62 oncogenic transformation 62 demyelinating 62 percutaneous biopsy 62 ABCB1 gene 62 ADAMTS# 62 kinase inhibition 62 tumor histology 62 microvessels 62 Squamous 62 #beta HSD1 62 methyltransferases 62 prognostic marker 62 T#M 62 endometrioid 62 HIF 1α 62 TGF beta pathway 62 heterochromatic 62 MLL gene 62 mRNA sequences 62 genetic abnormalities 62 HBV genotypes 62 FUS protein 62 estrogen receptor beta 62 clonal expansion 62 generalized vitiligo 62 histone deacetylase HDAC 62 pulmonary metastases 62 urine cytology 62 tRNA synthetases 62 FOXP3 62 PTEN mutations 62 metastatic lesions 62 c fos 62 aberrant activation 62 missense 62 metazoans 62 rDNA 62 myogenic 62 polynucleotides 62 oncogenic mutations 62 oligonucleotide microarrays 62 bcl 2 62 HLA molecules 62 HMGCR 62 heterologous expression 62 endogenous retroviruses 62 ribosomal RNA rRNA 62 effector protein 62 neuropathologic 62 HtrA2 62 protein tyrosine phosphatases 62 Cdc7 62 DCIS lesions 62 gp# protein [002] 62 protein tyrosine kinase 62 miRNA 62 Single Nucleotide Polymorphisms 62 yeast genome 62 adrenocortical cancer 62 small molecule activators 62 epigenetic silencing 62 synuclein

Back to home page